Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have received an average rating of “Hold” from the twelve research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $20.7778.

OSCR has been the subject of several recent analyst reports. Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and raised their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. UBS Group raised their price objective on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Weiss Ratings upgraded Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Friday, July 10th. Finally, Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th.

Oscar Health Stock Performance

Shares of OSCR stock opened at $30.59 on Thursday. The stock has a market cap of $9.22 billion, a P/E ratio of -51.84, a P/E/G ratio of 2.17 and a beta of 2.34. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The company has a fifty day moving average price of $26.61 and a two-hundred day moving average price of $18.78. Oscar Health has a one year low of $10.69 and a one year high of $33.10.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company’s quarterly revenue was up 52.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.92 EPS. As a group, equities analysts predict that Oscar Health will post 0.47 EPS for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the transaction, the insider directly owned 218,096 shares in the company, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the completion of the transaction, the insider directly owned 259,057 shares in the company, valued at $5,683,710.58. The trade was a 4.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 3,662,466 shares of company stock worth $105,145,815. 22.64% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. BIT Capital GmbH boosted its stake in Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the period. Morgan Stanley increased its position in Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after buying an additional 2,043,758 shares during the period. Bank of America Corp DE increased its position in Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after buying an additional 1,922,732 shares during the period. Thrive Capital Management LLC lifted its holdings in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares in the last quarter. Finally, Wedge Capital Management L L P NC acquired a new stake in shares of Oscar Health during the second quarter worth $32,855,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.